Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome
Abstract Background Non-alcoholic fatty liver (NAFLD) and its related metabolic syndrome have become major threats to human health, but there is still a need for effective and safe drugs to treat these conditions. Here we aimed to identify potential drug candidates for NAFLD and the underlying molec...
Saved in:
Main Authors: | Ruifeng Tian (Author), Jinjie Yang (Author), Xiaoming Wang (Author), Shuaiyang Liu (Author), Ruixiang Dong (Author), Zhenya Wang (Author), Zifeng Yang (Author), Yingping Zhang (Author), Zhiwei Cai (Author), Hailong Yang (Author), Yufeng Hu (Author), Zhi-Gang She (Author), Hongliang Li (Author), Junjie Zhou (Author), Xiao-Jing Zhang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioactive Lignan Honokiol Alleviates Ovarian Oxidative Stress in Aging Laying Chickens by Regulating SIRT3/AMPK Pathway
by: Yiqiu Chen, et al.
Published: (2024) -
Honokiol attenuates lipotoxicity in hepatocytes via activating SIRT3-AMPK mediated lipophagy
by: Jingxin Liu, et al.
Published: (2021) -
Mesenchymal Stem Cells for Cardiac Regenerative Therapy: Optimization of Cell Differentiation Strategy
by: Han Shen, et al.
Published: (2015) -
Counteracting Cisplatin-Induced Testicular Damages by Natural Polyphenol Constituent Honokiol
by: Tse-En Wang, et al.
Published: (2020) -
Honokiol as an α-glucosidase inhibitor
by: Hua Zhu, et al.
Published: (2024)